Patterson Companies, INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

Patterson Companies updates its proxy statement to address shareholder lawsuits alleging insufficient disclosures regarding the merger with Patient Square Capital, aiming to avoid delays and associated costs.
Patterson Companies, Inc. announces a definitive agreement to be acquired by Paradigm Parent, LLC, an affiliate of Patient Square Capital, for $31.35 per share in cash.
Patterson Companies has filed a preliminary proxy statement regarding its proposed merger with Patient Square Capital, outlining the details of the transaction and the upcoming shareholder vote.
Patterson Companies announced the expiration of the go-shop period related to its acquisition by Patient Square Capital for $31.35 per share, with the transaction expected to close in April 2025.
Patterson Companies has agreed to be acquired by Patient Square Capital for $31.35 per share, with the transaction expected to close in the fourth fiscal quarter of 2025.
Patterson Companies is set to be acquired by a private investment firm, transitioning from public to private ownership.
Patterson Companies has announced it will be acquired by Patient Square Capital, with the transaction expected to close in the fourth fiscal quarter of 2025.
Patterson Companies has agreed to be acquired by Patient Square Capital for $31.35 per share in cash, taking the company private.
Patterson Companies has agreed to be acquired by Patient Square Capital in a deal valued at approximately $4.1 billion, including the refinancing of receivables facilities.
Patterson Companies has agreed to be acquired by Patient Square Capital for $31.35 per share in cash, valuing the transaction at approximately $4.1 billion.
Patterson Companies, Inc. has filed a definitive proxy statement with the Securities and Exchange Commission.
Patterson Companies' proxy statement outlines the agenda for the upcoming annual shareholder meeting, director nominees, executive compensation, and corporate governance practices.